blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2308854

EP2308854 - 2,3,6-trisubstituted-4-pyrimidone derivatives [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.06.2014
Database last updated on 30.10.2024
Most recent event   Tooltip20.06.2014Application deemed to be withdrawnpublished on 23.07.2014  [2014/30]
Applicant(s)For all designated states
SANOFI
54, rue La Boétie
75008 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
[N/P]
Former [2012/18]For all designated states
SANOFI
54 rue La Boétie
75008 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
Former [2012/17]For all designated states
SANOFI
54, rue de la Boétie
75008 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
Former [2011/30]For all designated states
SANOFI
174, Avenue de France
75013 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
Former [2011/15]For all designated states
Sanofi-Aventis
174, Avenue de France
75013 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
Inventor(s)01 / Watanabe, Kazutoshi
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
02 / Uehara, Fumiaki
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
03 / Hiki, Shinsuke
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Toyko Tokyo 103-8405 / JP
04 / Yokoshima, Satoshi
I-201, Casa Hiko, 3-12-3, Yanaka, Adachi-ku
Tokyo 1200006 / JP
05 / Kohara, Toshiyuki
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Toyko Tokyo 103-8405 / JP
06 / Fukunaka, Kenji
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
07 / Usui, Yoshihiro
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
08 / Okuyama, Masahiro
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Toyko Tokyo 103-8405 / JP
09 / Shoda, Aya
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
10 / Aritomo, Keiichi
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
 [2011/17]
Former [2011/15]01 / Watanabe, Kazutoshi
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
02 / Uehara, Fumiaki
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
03 / Hiki, Shinsuke
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Toyko Tokyo 103-8405 / JP
04 / Yokoshima, Satoshi
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Toyko Tokyo 103-8405 / JP
05 / Kohara, Toshiyuki
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Toyko Tokyo 103-8405 / JP
06 / Fukunaka, Kenji
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
07 / Usui, Yoshihiro
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
08 / Okuyama, Masahiro
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Toyko Tokyo 103-8405 / JP
09 / Shoda, Aya
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
10 / Aritomo, Keiichi
Mitsubishi Pharma Corporation c/o Mitsubishi Pharma Corporation, Tokyo Office, 2-6 Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo Tokyo 103-8405 / JP
Representative(s)Godemeyer Blum Lenze Patentanwälte Partnerschaft mbB - werkpatent
An den Gärten 7
51491 Overath / DE
[N/P]
Former [2013/52]Godemeyer Blum Lenze - werkpatent
An den Gärten 7
51491 Overath / DE
Former [2012/02]Polypatent
An den Gärten 7
51491 Overath / DE
Former [2011/15]Polypatent
Braunsberger Feld 29
51429 Bergisch Gladbach / DE
Application number, filing date10192283.926.03.2004
[2011/15]
Priority number, dateJP2003012602126.03.2003         Original published format: JP 2003126021
JP2003012602226.03.2003         Original published format: JP 2003126022
[2011/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2308854
Date:13.04.2011
Language:EN
[2011/15]
Search report(s)(Supplementary) European search report - dispatched on:EP22.02.2011
ClassificationIPC:C07D239/47, C07D401/14, C07D405/14, C07D409/14, C07D413/14, C07D417/14, C07D403/14, A61K31/513, A61K31/5377, A61P25/28
[2011/15]
CPC:
C07D401/04 (EP,US); C07D401/14 (EP,KR,US); A61P17/14 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P43/00 (EP); A61P9/10 (EP); C07D239/47 (KR);
C07D403/14 (KR); C07D405/14 (EP,US); C07D409/14 (EP,US);
C07D413/14 (EP,US); C07D417/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/15]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:2,3,6-trisubstituierte-4-Pyrimidonderivate[2011/15]
English:2,3,6-trisubstituted-4-pyrimidone derivatives[2011/15]
French:Dérivés de 4-pyrimidone à substitution 2,3,6[2011/15]
Examination procedure10.10.2011Amendment by applicant (claims and/or description)
10.10.2011Examination requested  [2011/46]
22.11.2011Despatch of a communication from the examining division (Time limit: M06)
01.06.2012Reply to a communication from the examining division
02.10.2013Despatch of a communication from the examining division (Time limit: M04)
13.02.2014Application deemed to be withdrawn, date of legal effect  [2014/30]
10.03.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/30]
Parent application(s)   TooltipEP04723777.1  / EP1608630
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040723777) is  28.11.2008
Fees paidRenewal fee
17.03.2011Renewal fee patent year 03
17.03.2011Renewal fee patent year 04
17.03.2011Renewal fee patent year 05
17.03.2011Renewal fee patent year 06
17.03.2011Renewal fee patent year 07
15.03.2011Renewal fee patent year 08
14.03.2012Renewal fee patent year 09
11.03.2013Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.03.201411   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[ID]EP1136482  (SANOFI SYNTHELABO [FR], et al) [ID] 1-17 * claim 1 * * paragraph [0002] - paragraph [0006] * * page 15; example 38; table 1 *;
 [IP]WO03027080  (MITSUBISHI PHARMA CORP [JP], et al) [IP] 1-17 * page 104, line 9 - line 25 * * claims 1, 2, 10-25 * * page 66 - page 92; compounds C401-C499, C601-C651, C751-C768, D026-D050 *;
 [IP]WO03037888  (MITSUBISHI PHARMA CORP [JP], et al) [IP] 1-17 * page 9, line 21 - page 10, line 10 * * claims 1, 2, 11-13, 15-25 * * compounds C001-C099, C201-C251, C351-C368, C388, D001-D025 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.